NO20044573L - Farmasoytisk sammensetning omfattende arsenitt for behandling av malignhet - Google Patents

Farmasoytisk sammensetning omfattende arsenitt for behandling av malignhet

Info

Publication number
NO20044573L
NO20044573L NO20044573A NO20044573A NO20044573L NO 20044573 L NO20044573 L NO 20044573L NO 20044573 A NO20044573 A NO 20044573A NO 20044573 A NO20044573 A NO 20044573A NO 20044573 L NO20044573 L NO 20044573L
Authority
NO
Norway
Prior art keywords
treatment
arsenite
pharmaceutical composition
malignancy
composition
Prior art date
Application number
NO20044573A
Other languages
English (en)
Other versions
NO335317B1 (no
Inventor
Sang Bong Lee
Yong Jin Yang
Original Assignee
Yong Jin Yang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29244880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044573(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yong Jin Yang filed Critical Yong Jin Yang
Publication of NO20044573L publication Critical patent/NO20044573L/no
Publication of NO335317B1 publication Critical patent/NO335317B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det er beskrevet en farmasøytisk sammensetning for behandling av en fast malignhet som blir valgt fra gruppen bestående av tarmtumor, magetumor, brysttumor, ovarietumor, prostatatumor og nyretumor, idet nevnte sammensetning omfatter et salt av meta-arsenitt (AsO2-) og et farmasøytisk akseptabelt hjelpemiddel. Det er også beskrevet anvendelse og en fremgangsmåte for behandling.
NO20044573A 2002-04-10 2004-10-22 Anvendelse av natrium meta-arsenitt (NaAsO2) for fremstilling av en farmasøytisk sammensetning for behandling av en fast tumor NO335317B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2002/000231 WO2003086424A1 (en) 2002-04-10 2002-04-10 Pharmaceutical composition comprising arsenite for the treatment of malignancy

Publications (2)

Publication Number Publication Date
NO20044573L true NO20044573L (no) 2004-10-22
NO335317B1 NO335317B1 (no) 2014-11-10

Family

ID=29244880

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044573A NO335317B1 (no) 2002-04-10 2004-10-22 Anvendelse av natrium meta-arsenitt (NaAsO2) for fremstilling av en farmasøytisk sammensetning for behandling av en fast tumor

Country Status (25)

Country Link
US (1) US20050106262A1 (no)
EP (2) EP2042182B1 (no)
JP (1) JP2005525397A (no)
CN (1) CN1298332C (no)
AP (1) AP2004003167A0 (no)
AU (2) AU2002253713B2 (no)
BG (1) BG66356B1 (no)
BR (1) BR0215689A (no)
CA (1) CA2481602C (no)
CY (1) CY1114422T1 (no)
DK (2) DK2042182T3 (no)
EC (1) ECSP045408A (no)
ES (2) ES2425418T3 (no)
FI (1) FI1496918T3 (no)
HU (1) HU230851B1 (no)
IL (2) IL164470A0 (no)
LT (1) LT1496918T (no)
MX (1) MXPA04009898A (no)
NO (1) NO335317B1 (no)
NZ (1) NZ536452A (no)
PT (2) PT2042182E (no)
RO (1) RO123269B1 (no)
TN (1) TNSN04198A1 (no)
UA (1) UA80426C2 (no)
WO (1) WO2003086424A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789030A2 (en) * 2004-08-30 2007-05-30 Interstitial Therapeutics Medical implant provided with inhibitors of atp synthesis
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20090246291A1 (en) * 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
US20100249210A1 (en) * 2008-09-30 2010-09-30 Michael Bastiani Methods and compositions related to dlk-1 and the p38 mapk pathway in nerve regeneration
CN102060722B (zh) * 2009-05-01 2014-06-11 常州高新技术产业开发区三维工业技术研究所有限公司 一种含砷化合物及其制备方法和用途
KR20120061908A (ko) * 2009-09-10 2012-06-13 코미녹스 인코포레이티드 암 줄기세포-표적 및 약물 내성 암 치료
AU2010295841A1 (en) * 2009-09-18 2012-03-29 Kominox, Inc. Methods for treating brain tumors
CN101695501B (zh) * 2009-10-10 2013-08-14 广汉恒宇新材料有限公司 一种纳米尺寸亚砷酸的壳聚糖包载体及其制造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2183547C (en) * 1994-02-18 2002-05-14 Tamara Vasilievna Vorobieva Compositions for treating defective cell functions
PT1621077E (pt) * 1997-10-15 2008-11-04 Polarx Biopharmaceuticals Inc Composições farmacêuticas compreendendo trióxido de arsénico para o tratamento de um tumor do sistema nervoso central
CN1119152C (zh) * 1998-08-02 2003-08-27 哈尔滨医科大学第一临床医学院 治疗消化系统肿瘤注射液及其应用

Also Published As

Publication number Publication date
AU2008255139B2 (en) 2013-10-03
PT2042182E (pt) 2013-08-28
UA80426C2 (en) 2007-09-25
JP2005525397A (ja) 2005-08-25
CA2481602C (en) 2011-06-21
CN1625407A (zh) 2005-06-08
AP2004003167A0 (en) 2004-12-31
AU2002253713B2 (en) 2008-09-18
US20050106262A1 (en) 2005-05-19
CN1298332C (zh) 2007-02-07
PT1496918T (pt) 2023-05-25
EP1496918A1 (en) 2005-01-19
IL164470A0 (en) 2005-12-18
RO123269B1 (ro) 2011-05-30
NO335317B1 (no) 2014-11-10
FI1496918T3 (fi) 2023-05-11
ECSP045408A (es) 2006-03-01
ES2944907T3 (es) 2023-06-27
EP2042182A1 (en) 2009-04-01
NZ536452A (en) 2007-06-29
EP2042182B1 (en) 2013-05-22
HU230851B1 (en) 2018-09-28
HUP0500199A3 (en) 2008-03-28
DK2042182T3 (da) 2013-08-26
BG66356B1 (bg) 2013-09-30
AU2002253713A1 (en) 2003-10-27
CY1114422T1 (el) 2016-08-31
TNSN04198A1 (en) 2007-03-12
IL164470A (en) 2010-12-30
CA2481602A1 (en) 2003-10-23
ES2425418T3 (es) 2013-10-15
HUP0500199A2 (en) 2007-02-28
LT1496918T (lt) 2023-05-25
WO2003086424A1 (en) 2003-10-23
EP1496918B1 (en) 2023-02-08
AU2008255139A1 (en) 2009-01-08
BG108932A (en) 2005-11-30
BR0215689A (pt) 2005-02-01
DK1496918T3 (da) 2023-05-15
MXPA04009898A (es) 2005-06-20

Similar Documents

Publication Publication Date Title
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
EP1714961A4 (en) INDAZOL COMPOUND AND THEIR PHARMACEUTICAL USE
NO20092033L (no) Nye forbindelser
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
TW200801006A (en) Fused bicyclic mTOR inhibitors
MXPA05013977A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
GB0111523D0 (en) Chemical compounds
NO20052524L (no) Aminerte isofiavonoidderivater og anvendelse derav
DK1200412T3 (da) Antiproliferative imidazolforbindelser
NO20044573L (no) Farmasoytisk sammensetning omfattende arsenitt for behandling av malignhet
MXPA04004606A (es) Venenos de topoisomerasa solubilizados.
MY138550A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139159A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
NO20044466L (no) Plasma-karboksypeptidase B-inhibitorer
NO20035313L (no) Fremgangsmåte for fremstilling av tialzol PPAR-ligand og polymorfer derav
JP2005525397A5 (no)
MY139348A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
EA200700692A1 (ru) Пиридиновые производные индолин-2-она, их получение и их прменение в терапии
WO2002098399A3 (en) Cancer treatment method and compositions comprising compounds of the ginger family
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
TW200633701A (en) Thioether derivatives, their manufacture and use as pharmaceutical agents
UA80905C2 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts

Legal Events

Date Code Title Description
MK1K Patent expired